Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Chemokines in Psoriasis-An Overview. | Medicina (Kaunas) | 2021 | 34440960 | PubTator, text mining | PubMed |
| Post-Operative Adhesions: A Comprehensive Review of Mechanisms. | Biomedicines | 2021 | 34440071 | PubTator, text mining | PubMed |
| Hsa_circ_0134111 promotes osteoarthritis progression by regulating miR-224-5p/CCL1 interaction. | Aging (Albany NY) | 2021 | 34413269 | PubTator, text mining | PubMed |
| Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer. | Aging (Albany NY) | 2021 | 34413268 | PubTator, text mining | PubMed |
| The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer. | Aging (Albany NY) | 2021 | 34413267 | PubTator, text mining | PubMed |
| Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors. | Hum Gene Ther | 2021 | 34405686 | PubTator, text mining | PubMed |
| Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis. | Nat Commun | 2021 | 34404786 | PubTator, text mining | PubMed |
| SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters. | Nat Commun | 2021 | 34404778 | PubTator, text mining | PubMed |
| Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis. | Arthritis Res Ther | 2021 | 34391459 | PubTator, text mining | PubMed |
| Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis. | Sci Immunol | 2021 | 34389613 | PubTator, text mining | PubMed |
| Nox2-deficient Tregs improve heart transplant outcomes via their increased graft recruitment and enhanced potency. | JCI Insight | 2021 | 34375309 | PubTator, text mining | PubMed |
| Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream. | Pharmaceutics | 2021 | 34371735 | PubTator, text mining | PubMed |
| Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy. | Front Cell Dev Biol | 2021 | 34368124 | PubTator, text mining | PubMed |
| Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma. | Front Oncol | 2021 | 34367941 | PubTator, text mining | PubMed |
| Identification and Validation of PIK3CA as a Marker Associated with Prognosis and Immune Infiltration in Renal Clear Cell Carcinoma. | J Oncol | 2021 | 34367282 | PubTator, text mining | PubMed |
| TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer. | Front Immunol | 2021 | 34367161 | PubTator, text mining | PubMed |
| ERO1L Is a Novel and Potential Biomarker in Lung Adenocarcinoma and Shapes the Immune-Suppressive Tumor Microenvironment. | Front Immunol | 2021 | 34354701 | PubTator, text mining | PubMed |
| Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 34350177 | PubTator, text mining | PubMed |
| R-loop modulated epigenetic regulation in T helper cells mechanistically associates coronary artery disease and non-small cell lung cancer. | Transl Oncol | 2021 | 34343853 | PubTator, text mining | PubMed |
| Synthesis of Conformationally Liberated Yohimbine Analogues and Evaluation of Cytotoxic Activity. | ACS Omega | 2021 | 34337266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=47